Radiological Imaging in Head and Neck Tumours

  • Julian KabalaEmail author
  • Matthew Beasley
Part of the Clinicians’ Guides to Radionuclide Hybrid Imaging book series (CGRHI)


Imaging has a limited role in diagnosis [1]. Most head and neck (H&N) tumours are referred for imaging after the diagnosis has been confirmed or strongly suspected clinically. That said, with some less common malignancies, magnetic resonance imaging (MRI) has a more significant diagnostic role. Also, in people with squamous cell cancer (SqCC) neck nodes, and no obvious primary site on clinical examination, MRI/CT will demonstrate the primary in approximately one third of cases.


  1. 1.
    Arya S, Rane P, Deshmukh A. Oral cavity squamous cell carcinoma: role of pretreatment imaging and its influence on management. Clin Radiol. 2014;69(9):916–30.CrossRefPubMedGoogle Scholar
  2. 2.
    Bondt RBJ, Nelemans PJ, Hofman PAM, et al. Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging. Eur J Radiol. 2007;64:266–72.CrossRefPubMedGoogle Scholar
  3. 3.
    Fukuhara T. Usefulness of chest CT scan for head and neck cancer. Auris Nasus Larynx. 2015;42(1):49–52.: S0385-8146(14)00131-X. Scholar
  4. 4.
    Loh KS, Brown DH, Baker JT, et al. A rational approach to pulmonary screening in newly diagnosed head and neck cancer. Head Neck. 2005;27(11):990–4.CrossRefPubMedGoogle Scholar
  5. 5.
    Rennemo E, Zätterström U, Boysen M. Synchronous second primary tumors in 2,016 head and neck cancer patients: role of symptom-directed panendoscopy. Laryngoscope. 2011;121(2):304–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Priante AV, Castilho EC, Kowalski LP. Second primary tumors in patients with head and neck cancer. Curr Oncol Rep. 2011;13(2):132–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Jain KS, Sikora AG, Baxi SS, et al. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer. Cancer. 2013;119(10):1832–7. Epub 2013 Feb 19CrossRefPubMedGoogle Scholar
  8. 8.
    Offiah C, Hall E. Post-treatment imaging appearances in head and neck cancer patients. Clin Radiol. 2011;66:13–24.CrossRefPubMedGoogle Scholar
  9. 9.
    Lell M, Baum U, Greess H, et al. Head and neck tumours: imaging recurrent tumour and post-therapeutic changes with CT and MRI. Eur J Radiol. 2000;33:239–47.CrossRefPubMedGoogle Scholar
  10. 10.
    Collan J, Lundberg M, Vaalavirta L. Patterns of relapse following surgery and postoperative intensity modulated radiotherapy for oral and oropharyngeal cancer. Acta Oncol. 2011;50(7):1119–25.CrossRefPubMedGoogle Scholar
  11. 11.
    Som PM, Urken ML, Biller H, et al. Imaging the postoperative neck. Radiology. 1993;187:593–603.CrossRefPubMedGoogle Scholar
  12. 12.
    Kangelaris GT, Yom SS, Huang K et al. Limited utility of routine surveillance MRI following chemoradiation for advanced-stage oropharynx carcinoma. Int J Otolaryngol. 2010;2010. pii: 904297. Epub 2010 Aug 31.
  13. 13.
    de Bree R, van der Putten L, Brouwer J, et al. Detection of locoregional recurrent head and neck cancer after (chemo)radiotherapy using modern imaging. J Neuropathol Exp Neurol. 2013;72(7):600–13.CrossRefGoogle Scholar
  14. 14.
    Nishimura G, Matsuda H, Taguchi T. Treatment evaluation of metastatic lymph nodes after concurrent chemoradiotherapy in patients with head and neck squamous cell carcinoma. Anticancer Res. 2012;32(2):595–600.PubMedGoogle Scholar
  15. 15.
    Newbold K, Powell C. PET/CT in radiotherapy planning for head and neck cancer. Front Oncol. 2012;2(189):2234–943.Google Scholar
  16. 16.
    Tsien C, Cao Y, Chenevert T. Clinical applications for diffusion magnetic resonance imaging in radiotherapy. Semin Radiat Oncol. 2014;24(3):218–26.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Alberico RA, Husain SH, Sirotkin I. Imaging in head and neck oncology. Surg Oncol Clin N Am. 2004;13(1):13–35.CrossRefPubMedGoogle Scholar
  18. 18.
    Rumboldt Z, Gordon L, Bonsall R, et al. Imaging in head and neck cancer. Curr Treat Options Oncol. 2006;7(1):23–34.CrossRefPubMedGoogle Scholar
  19. 19.
    Evangelista L, Cervino AR, Chondrogiannis S, et al. Comparison between anatomical cross-sectional imaging and 18F-FDG PET/CT in the staging, restaging, treatment response, and long-term surveillance of squamous cell head and neck cancer: a systematic literature overview. Nucl Med Commun. 2014;35(2):123–34.CrossRefPubMedGoogle Scholar
  20. 20.
    Nutting C. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011;12(2):127–36.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Miah A. Dose-escalated intensity-modulated radiotherapy is feasible and may improve locoregional control and laryngeal preservation in laryngo-hypopharyngeal cancers. Int J Radiat Oncol Biol Phys. 2012;82(2):539–47.CrossRefPubMedGoogle Scholar
  22. 22.
    Imaizumi A, Yoshino N, Yamada I, et al. A potential pitfall of MR imaging for assessing mandibular invasion of squamous cell carcinoma in the mandible. AJNR Am J Neuroradiol. 2006;27:114–22.PubMedGoogle Scholar
  23. 23.
    Vidiri A, Guerrisi A, Pellini R, et al. Multi-detector row computed tomography (MDCT) and magnetic resonance imaging (MRI) in the evaluation of the mandbiular invasion by squamous cell carcinomas (SCC) of the oral cavity. Correlation with pathological data. J Exp Clin Cancer Res. 2010;29:73–9.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Handschel J, Naujoks C, Depprich RA, et al. CT-scan is a valuable tool to detect mandibular involvement in oral cancer patients. Oral Oncol. 2012;48:361–6.CrossRefPubMedGoogle Scholar
  25. 25.
    Li C, Men Y, Yang W, et al. Computed tomography for the diagnosis of mandibular invasion caused by head and neck cancer: a systematic review comparing contrast-enhanced and plain computed tomography. J Oral Maxillofac Surg. 2014;72:1601–15.CrossRefPubMedGoogle Scholar
  26. 26.
    Goerres GW, Schmid DT, Schuknecht B, et al. Bone invasion in patients with oral cavity cancer: comparison of conventional CT with PET/CT and SPECT/CT. Radiology. 2005;237:281–7.CrossRefPubMedGoogle Scholar
  27. 27.
  28. 28.
  29. 29.
    Barrett JF, Keat N. Artifacts in CT: recognition and avoidance. Radiographics. 2004;24:1679–91.CrossRefPubMedGoogle Scholar
  30. 30.
    Cai P, Yao-pan W, Li L, et al. CT and MRI of radiation-induced sarcomas of the head and neck following radiotherapy for nasopharyngeal carcinoma. Clin Radiol. 2013;68:683–9.CrossRefPubMedGoogle Scholar
  31. 31.
    Chong J, Hinkley LK, Ginsberg LE. Masticator space abnormalities associated with mandibular osteoradionecrosis. AJNR Am J Neuroradiol. 2000;21:175–8.PubMedGoogle Scholar
  32. 32.
    Hermans R. Imaging of mandibular osteoradionecrosis. Neuroimaging Clin N Am. 2003;13:597–604.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of RadiologyUniversity Hospitals Bristol NHS Trust, Bristol Royal InfirmaryBristolUK
  2. 2.University Hospitals Bristol NHS Foundation Trust, Bristol Haematology and Oncology CentreBristolUK

Personalised recommendations